From: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
 | COPD Subjects | Smoker Controls |  | Non-smoker Controls |  | |||
---|---|---|---|---|---|---|---|---|
Biomarker | N | Median (IQR) | N | Median (IQR) | COPD Subjects vs Smoker Controls | N | Median (IQR) | COPD Subjects vs Non-smoker Controls |
Adiponectin (ng/mL)* | 198 | 15614.5 (10340.0) | 37 | 10856.0 (6145.0) | < 0.001 | 36 | 16124.5 (6428.5) | 0.270 |
β-Defensin-2 (pg/mL)* | 199 | 1222.3 (1794.8) | 37 | 771.6 (784.2) | 0.003 | 37 | 648.2 (964.1) | 0.042 |
CCL2 (pg/mL) | 201 | 615.0 (395.0) | 37 | 530.0 (365.0) | 0.065 | 37 | 460.0 (445.0) | 0.017 |
CCL18 (pg/mL) | 193 | 96000.0 (93000.0) | 37 | 67000.0 (40000.0) | 0.018 | 35 | 68000.0 (34000.0) | 0.041 |
C-reactive protein (μg/mL) | 200 | 5.38 (10.62) | 37 | 3.13 (5.27) | 0.036 | 35 | 2.17 (3.96) | 0.002 |
CXCL10 (pg/mL) | 198 | 79.7 (38.0) | 37 | 67.8 (26.6) | 0.085 | 35 | 65.8 (30.4) | 0.017 |
Fibrinogen (mg/dL) | 200 | 466.0 (117.5) | 37 | 425.0 (100.0) | 0.002 | 37 | 387.0 (83.0) | < 0.001 |
Hepatocyte growth factor (pg/mL) | 199 | 589.2 (492.7) | 37 | 475.3 (303.6) | 0.324 | 37 | 421.7 (217.7) | 0.012 |
Interleukin-6 (pg/mL) | 194 | 0.2 (2.8) | 37 | 0.2 (0.0) | 0.004 | 37 | 0.2 (0.4) | 0.072 |
Interleukin-8 (pg/mL) | 190 | 8.8 (5.2) | 36 | 7.7 (4.8) | 0.051 | 34 | 6.7 (3.0) | 0.009 |
Interleukin-12 p40 (pg/mL) | 177 | 1.6 (2.8) | 32 | 2.3 (3.5) | 0.343 | 32 | 0.6 (2.3) | 0.017 |
Matrix metalloproteinase-8 (pg/mL)* | 198 | 9005.8 (10853.0) | 37 | 7393.7 (7231.2) | 0.003 | 37 | 6607.9 (5241.8) | < 0.001 |
Matrix metalloproteinase-9 (pg/mL) | 201 | 238020.0 (202960.0) | 37 | 182700.0 (92460.0) | 0.198 | 37 | 158180.0 (85815.0) | < 0.001 |
Myeloperoxidase (pg/mL) | 198 | 34680.0 (34305.0) | 36 | 24770.0 (19280.0) | 0.195 | 37 | 20800.0 (17100.0) | 0.043 |
Prolactin (pg/mL) | 196 | 525.0 (462.5) | 37 | 345.0 (260.0) | < 0.001 | 36 | 580.0 (325.0) | 0.771 |